Back to Search Start Over

Hydrophobic deep eutectic solvent (HDES) as oil phase in lipid-based drug formulations.

Authors :
Panbachi, Shaida
Beranek, Josef
Kuentz, Martin
Source :
International Journal of Pharmaceutics. Aug2024, Vol. 661, pN.PAG-N.PAG. 1p.
Publication Year :
2024

Abstract

[Display omitted] • A hydrophobic deep eutectic solvent (HDES) is developed as a novel oil phase for LBFs. • Phase diagrams are modeled to describe the thermodynamic behavior of the HDES. • Molecular dynamics simulations are performed to examine the formulation architecture. • The HDES solubilized more venetoclax compared to conventional oil-phase candidates. • Combined with Tween 80, the HDES resulted in supersaturated venetoclax release. There is increasing pharmaceutical interest in deep eutectic solvents not only as a green alternative to organic solvents in drug manufacturing, but also as liquid formulation for drug delivery. The present work introduces a hydrophobic deep eutectic solvent (HDES) to the field of lipid-based formulations (LBF). Phase behavior of a mixture with 2:1 M ratio of decanoic- to dodecanoic acid was studied experimentally and described by thermodynamic modelling. Venetoclax was selected as a hydrophobic model drug and studied by atomistic molecular dynamics simulations of the mixtures. As a result, valuable molecular insights were gained into the interaction networks between the different components. Moreover, experimentally the HDES showed greatly enhanced drug solubilization compared to conventional glyceride-based vehicles, but aqueous dispersion behavior was limited. Hence surfactants were studied for their ability to improve aqueous dispersion and addition of Tween 80 resulted in lowest droplet sizes and high in vitro drug release. In conclusion, the combination of HDES with surfactant(s) provides a novel LBF with high pharmaceutical potential. However, the components must be finely balanced to keep the integrity of the solubilizing HDES, while enabling sufficient dispersion and drug release. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
03785173
Volume :
661
Database :
Academic Search Index
Journal :
International Journal of Pharmaceutics
Publication Type :
Academic Journal
Accession number :
178681926
Full Text :
https://doi.org/10.1016/j.ijpharm.2024.124418